SCHEMBL3387608

SCHEMBL3387608

Cc1ccc(S(=O)(=O)OCC2CCCNC2)cc1

nearest known ligand 0.43

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KDM1A O60341 3/20 0.43
HTR6 P50406 1/20 0.41
CHRNB2 P17787 2/20 0.40
CHRNA4 P43681 2/20 0.40
IKBKB O14920 1/20 0.40
CHUK O15111 1/20 0.40
CHRNB4 P30926 1/20 0.40
CHRNA3 P32297 1/20 0.40
SCN9A Q15858 1/20 0.39
MAP2K1 Q02750 1/20 0.39
EED O75530 1/20 0.39
SYK P43405 3/20 0.38
AURKB Q96GD4 3/20 0.38
KCNH2 Q12809 2/20 0.38
CYP2D6 P10635 2/20 0.37
KMT2A Q03164 1/20 0.37
CYP1A2 P05177 1/20 0.37
HRH4 Q9H3N8 1/20 0.37
HRH3 Q9Y5N1 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8790104 0.92 HTR6 (0.45) KDM1AHTR6CHRNB2CHRNA4KCNH2
SCHEMBL8790095 0.92 HTR6 (0.45) KDM1AHTR6CHRNB2CHRNA4KCNH2
SCHEMBL16797263 0.92 HTR6 (0.45) KDM1AHTR6CHRNB2CHRNA4KCNH2
SCHEMBL14385136 0.86 KMT2A (0.41) KDM1AHTR6CHRNB2CHRNA4CHRNB4
SCHEMBL4719653 0.85 HTR6 (0.40) HTR6CYP2D6CYP1A2
SCHEMBL79261 0.84 ALDH1A1 (0.46) CYP2D6CYP1A2
SCHEMBL283868 0.84 ACHE (0.46) CYP2D6KMT2ACYP1A2
SCHEMBL7360511 0.82 HTR6 (0.50) KDM1AHTR6KCNH2CYP2D6KMT2A
SCHEMBL1553777 0.82 ALDH1A1 (0.49) KCNH2CYP2D6KMT2ACYP1A2
SCHEMBL5561307 0.82 ALDH1A1 (0.49) KCNH2CYP2D6KMT2ACYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2029534-B1 1H-INDOL-5-YL-PIPERAZIN-1-YL-METHANONE DERIVATIVES HOFFMANN LA ROCHE (CH) 2010-12-22 EP disclosed
EP-2029534-A2 1H-INDOL-5-YL-PIPERAZIN-1-YL-METHANONE DERIVATIVES F. Hoffmann-Roche AG (CH) 2009-03-04 EP disclosed
US-7432255-B2 1H-indol-5-yl-piperazin-1-yl-methanone derivatives HOFFMANN-LA ROCHE INC. (US) 2008-10-07 US disclosed
WO-2007131907-A2 1H-INDOL-5-YL-PIPERAZIN-1-YL-METHANONE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2007-11-22 WO disclosed
US-20070270423-A1 IH-indol-5-YL-piperazin-1-YL-methanone derivatives HOFFMANN-LA ROCHE INC. 2007-11-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070270423-A1 IH-indol-5-YL-piperazin-1-YL-methanone derivatives HRH4, HRH2, HRH3 KDM1A 613/4885HTR6 21/4885CHRNB2 434/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.